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Abstract: The use of autologous stem/progenitor cells represents a promising approach to the 
repair of craniofacial bone defects. The calvarium is recognized as a viable source of 
stem/progenitor cells that can be transplanted in vitro to form bone. However, it is unclear if 
bone formed in cell culture is similar in quality to that found in native bone. In this study, the 
quality of bone mineral formed in osteogenic cell cultures were compared against calvarial bone 
from postnatal mice. Given the spectroscopic resemblance that exists between cell and collagen 
spectra, the feasibility of extracting information on cell activity and bone matrix quality were 
also examined. Stem/progenitor cells isolated from fetal mouse calvaria were cultured onto 
fused-quartz slides under osteogenic differentiation conditions for 28-days. At specific time 
intervals, slides were removed and analyzed by Raman microscopy and mineral staining 
techniques. We show that bone formed in culture at day-28 resembled calvarial bone from 1-day 
old postnatal mice with comparable mineralization, mineral crystallinity, and collagen crosslinks 
ratios. In contrast, bone formed at day-28 contained a lower degree of ordered collagen fibrils 
compared to 1-day old postnatal bone. Taken together, bone formed in osteogenic cell culture 
exhibited progressive matrix maturation and mineralization but could not fully replicate the high 
degree of collagen fibril order found in native bone. 
 





Bone defects, particularly of the craniofacial complex, are a complication of trauma, congenital 
malformation, or tumor surgery.[1-3] Despite significant advances in craniofacial bone repair, 
there is an additional risk of bone loss through post-operative bone resorption, infection, 
abnormal bone healing, or radiotherapy.[3-6] Small bone defects and bone losses can be repaired 
using autologous bone grafts, but for more extensive repairs and repeated surgeries, alloplastic 
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bone substitutes or banked bone allografts can be used.[6, 7] Other promising biomaterials for 
craniofacial bone repair include tissue-engineered constructs, [8] which are ideally seeded with 
osteogenic stem/progenitor cells sourced from the patient’s own body.[9-11] Although, the use of 
autologous stem/progenitor cells would overcome issues of immunorejection, challenges still 
remain in identifying suitable human bone-forming cells that meet the clinical need, including 
the need to assess the quality of bone formed in preclinical models.[7, 11-13] 
Stem/progenitor cell selection and enrichment are two of several important prerequisites that 
need to be satisfied in developing tissue-engineered therapies for craniofacial bone repair.[14] In 
mice, the stem cell antigen (Sca-1) is widely used to enrich hematopoietic stem cells, including 
stem, progenitor, and differentiated cells from a variety of tissue types, such as bone marrow, 
bone, muscle, cardiac, vascular endothelium, and skin.[15] By combining cell sorting with 
negative Sca-1 selection, enriched stem and/or progenitor cell fractions can be obtained from 
neonatal or adult mice. Recent studies have shown that fetal and postnatal mouse calvaria can 
also provide a source of osteogenic stem/progenitor cells, which can be enriched by negative 
Sca-1 immunomagnetic selection (Sca-1-).[16, 17] Sca-1- cell fractions can form bone in vitro or be 
loaded into absorbable gelatin sponges and then transplanted into mice to form bone in vivo.[17] 
Sca-1 expression is known to vary between different mouse strains and tissue types,[12, 18] and 
thus it would be necessary to evaluate their osteogenic potential and the quality of bone formed 
in vitro. Evaluation of osteogenic potential becomes apparent considering that Sca-1- and 
positive Sca-1 (Sca-1+) cell selection can also be used to enrich chondroprogenitor and 
adipoprogentior cells, respectively, and thus if given the appropriate culture conditions would 
form their corresponding cartilage and adipose tissue types.[16, 17] Current osteogenic assays 
include alkaline phosphatase (ALP) to detect osteoblastic differentiation and histochemical 
mineral stains, such as von Kossa and Alizarin Red to quantify phosphate and calcium levels in 
vitro, respectively. However, mineral stains are non-specific,[19, 20] and thus cell culture studies 
would also benefit from complementary bone quality assessments performed by Raman or FTIR 
spectroscopy.  
Raman spectroscopy can be used to follow the osteogenic differentiation of various cell 
phenotypes in culture,[21] as well as document the real-time formation and accumulation of bone 
mineral in cell or organ culture systems.[22, 23] In this static time-dependent study, Raman 
microscopy and mineral stains were used to examine the bone-forming potential of Sca-1- 
stem/progenitor cells derived from fetal mouse calvarias. The relative quantity and maturity of 
the bone mineral formed over a 28-day culture period was also compared against reference 
measurements obtained from postnatal calvarial tissues. Given the high plating densities of cells 
used in this study and their spectroscopic resemblance to type I collagen, the feasibility of using 
Raman microscopy to assess cell activity and bone matrix quality were also examined.  
 
Materials and methods 
 
Sca-1- cell isolation, plating, and osteogenic differentiation 
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All experiments were approved by the Institutional Animal Care and Use Committee (UCUCA) 
at the University of Michigan.[16] Fetal-day 18.5-old B6CBAF1/J mice calvarial tissues were 
harvested and cells obtained by sequential enzymatic digestion.[16] Sca-1- cell fractions were 
plated, expanded, and incubated using standard cell cultivation techniques.[16] Confluent Sca-1- 
cells were passaged once prior to re-plating at 10,000 cells/cm2 on sterilized fused-quartz slides 
(S1-UV grade, 12.7-mm circulars, Esco Products, Oak Ridge, NJ). Fused-quartz slides were used 
because of their low Raman background compared to glass, [24, 25] and their ability to maintain 
cell proliferation and morphology.[26, 27] At confluence, expansion media was replaced by 
osteogenic culture media (DMEM-Low Glucose media containing 2% fetal bovine calf serum, 
10 mM β-glycerophosphate, 0.1 µM dexamethasone, and 0.2 mM ascorbic acid 2-phosphate) to 
induce osteogenic differentiation.[16, 28] The osteogenic media was refreshed every 2-3 days. 
 
 
Raman microscopy and spectral acquisition 
 
At the following time intervals: 1, 4, 8, 14, 17, 25, and 28-days (n=3 slides per time interval), the 
osteogenic culture media was removed, quartz slides rinsed once with PBS solution, and fixed 
with ice-cold 70% ethanol.[29] After air-drying the slides in a laminar flow hood, they were 
sampled using Raman microscope equipped with a 785 nm laser.[25] The spectrograph was fitted 
with a 50-μm slit to provide a spectral resolution of 6-8 cm-1. The excitation laser was spot-
focused through a 50x0.80 NA objective (Nikon Instruments, Inc.,) to give ~23 mW laser power 
at the sample. The slide was placed onto a gridded reference slide (Electron Microscopy 
Sciences, Hatfield, PA) to allow the sampled sites to be re-located and re-imaged after von Kossa 
staining. For each sample slide, 12-18 spectra were acquired from suspected mineralizing sites. 
Spectra were acquired using 12-min acquisition times. All sample and calibration spectra were 
processed in MATLAB® Software (The MathWorks Inc., Natick, MA) using locally written 




After spectral analysis, one set of sample slides were stained for inorganic phosphate using the 
von Kossa technique described elsewhere.[17] The remaining slides were stained for calcium 
using a freshly prepared and filtered 1% Alizarin Red solution (pH ~4.2).[29] After 2 mins, the 
dye solution was removed, and the slides rinsed with deionized water to remove any non-specific 
binding of the dye to the extracellular matrix (ECM). Mineral formed by Sca-1- cells cultured in 
a single 15-mm-diameter polystyrene well-plate at day-28 was also prepared and stained for 
calcium.[16] All Alizarin Red stained cell quartz slides and polystyrene well-plate were imaged 
using a SMZ800 stereomicroscope (Nikon Instruments, Inc.,).  
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Spectroscopic reference materials 
 
Fresh cortical calvarial tissues were harvested from postnatal day-1 (PN1) and postnatal day-56 
(PN56) old male B6CBAF1/J mice (n=3 per group).[16, 25] Parietal-suture-parietal calvarial tissue 
sections were isolated, cleaned, and stored in a petri dish containing calcium buffered saline 
solution at 4°C. Prior to Raman spectroscopic sampling, the tissue section was placed flat onto a 
quartz slide. For each tissue section, 6 spectra were acquired from the mineralized cortical 
parietal regions on either side of the central suture region using the acquisition parameters 
outlined above. Raman spectra were also acquired from the following reference materials: 
bovine Achilles type I collagen (Sigma Aldrich Co., St Louis, MO); triglyceride mixtures (Sigma 
Aldrich Co.,), synthetic powdered hydroxyapatite (n=3, Catalogue # 289396 with lot numbers: 
MKBC4763, MKBK2210V, and 06616CS; Sigma Aldrich Co.,); Gly-Pro-Hyp synthetic peptide 
(Bachem Biosciences Inc., King of Prussia, PA), and calf joint proteoglycan (Elastin Products 
Co., Inc. Owensville, MO). All materials were used as received, except for the triglycerides in 
which 4µL aliquots on a fused-quartz slide were allowed to air-dry prior to acquisition.  
 
Curve-fit spectral analysis 
 
Sample spectra were imported into GRAMS/AI® Software (ThermoGalactic Inc., Salem, NH) for 
further processing. Briefly, background spectra of bare fused-quartz and sample slides were 
normalized to the intensity of the silica band at ~786 cm-1, followed by spectral subtraction and 
smoothing using the Savitisky-Golay function (2nd order polynomial, 7-point of smoothing).[24, 30] 
Manual baseline correction was then applied to the 740-1750 cm-1 spectral region, followed by 
normalization to the intensity of the amide I C=O band at ~1666 cm-1. Spectra showing evidence 
for bone mineral (ca. v1(PO43-) band between 955-960 cm-1) were separated from spectra 
containing mainly bone matrix (ca. resolvable v(C-C) protein backbone band at ~939 cm-1). 
Spectra containing strong lipid δ(=CH) band at ~1295 cm-1 or glycosaminoglycan (GAG) δ(CH3) 
band at ~1378 cm-1 were excluded, owing to their potential overlap with the major matrix proline 
ν(C-C) and amide I ν(C=O) bands at ~854 and ~1666 cm-1, respectively. The sharp band at 
~1554 cm-1 in some spectra was identified as an optical artifact, and thus can be ignored.  
   For curve-fit analysis, second-derivative and constrained Gaussian deconvolution functions 
were applied to the following spectral regions: 740-910, 900-990, 1185-1400, and 1630-1710 
cm-1. Tentative band assignments for the following key osteogenic culture components were 
made: cell tryptophan (Typ) protein band at ~757 cm-1, cell nucleic acid v(P-O-P) band at ~782 
cm-1; matrix proline v(C-C) band at ~854 cm-1; mineral v1(PO43-) band between 955-960 cm-1; 
amide III v(C-N) + δ(N-H) bands at ~1246 cm-1 (α-helical or ordered structure) and ~1264 cm-1 
(β-sheet or disordered structure); and amide I v(C=O) bands at ~1666 cm-1 (non-reducible 
trivalent collagen crosslinks) and ~1693 cm-1 (reducible divalent collagen crosslinks).[31-33] Band 
position, bandwidth, and/or intensity ratios between select Raman bands, which contained 
information on cell activity and bone quality were extracted.[31, 34] Briefly, the mineral 
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crystallinity parameter was calculated from the bandwidth of the mineral v1(PO43-) band at full-
width at half maximum (FWHM).[31] Mineral/matrix ratios were derived from the mineral 
v1(PO43-) and proline v(C-C) band intensities.[27, 31, 35] Nucleic acid/Typ, collagen disorder/order, 
and collagen crosslinks ratios were based on: 781/854, 1246/1264, and 1666/1693 cm-1 
ratiometric parameters, respectively.[31] Lipid/matrix ratios were not calculated because of the 
possible dissolution of lipids by ethanol during the fixation step.[34] In addition, given that all 
spectra were acquired using a high NA-objective, we advise that the intensity of the amide III 
sub-band at ~1270 cm-1 used to calculate the 1240/1270 cm-1 ratios may also exhibit some 




Statistical analyses were performed in SPSS Statistics Software for Windows (IBM SPSS 
Statistics Version 24, IBM Corp., NY). All results are presented as means ± standard derivations 
(SDs). Due to the small sample size of n=3 per group, power analyses between day-8, day-28, 
PN1, PN56, and/or HA comparisons were performed in nQuery Advisor Software using the 
Satterhwaite t-test.[38] Only Raman spectroscopic results that were sufficiently powered to claim 
statistical significances at 80 % power (two-sided, α=0.05) were reported in this study. Two-
tailed independent sample t-tests with Bonferroni corrections were then applied to comparisons 
between day-8, day-28, PN1, PN56, and/or HA groups (34 simultaneous tests). Statistically 
significant differences were considered at the p<0.0015 (0.05/34) level. Bar plots and the 
regression plot were created using the software, Microsoft Excel 2010. The linear correlation 
between mineral crystallinity and band position of the mineral v1(PO43-) vibration was examined 
and the R2 value and equation of the line reported.  
 
Results and discussion 
 
Temporal mineralization of Sca-1- cell cultures    
 
Sca-1- cells took 3-4 days to achieve confluency on fused-quartz slides and displayed normal 
spindle-to-oval shaped morphologies that were similar to those observed previously on 
polystyrene plates.[16, 17] As shown in Fig. S1a-g, mineral formed by osteogenic Sca-1- cell 
cultures were visualized by Alizarin Red staining at various time intervals over the 28-day 
culture period. Mineral-like deposits were first detected at day-8. Thereafter, the frequency, size, 
and complexity of the mineralized bone nodules increased with culture time. The heterogeneous 
distribution of the bone nodules was expected given that primary Sca-1- cells were passaged only 
once prior to re-plating, and thus retained their mixed osteogenic stem/progenitor cell 
phenotypes.[39] The appearance of the bone nodules formed on the quartz slide at day-28 (Fig. 
S1g) resembled those formed on polystyrene culture plate at day-28 (Fig. S1h) in this study, and 
in a previous study using the von Kossa staining technique.[16]  
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Spectroscopic components of osteogenic cell cultures  
 
Prior to evaluating the quality of bone formed in culture, it was necessary to spectroscopically 
characterize the key cell culture components formed under osteogenic differentiation with 
assistance from mineral staining techniques. Fig. 1 shows the von Kossa stain images taken at 
specific time intervals over the 28-day culture period with site-matched spectra. As shown in Fig. 
1e, cultures were not stained black for inorganic phosphate until day-8. The associated spectrum 
shown in Fig. 1f contained the distinct mineral v1(PO43-) band at ~958 cm-1,[31] which was absent 
from the adjacent non-mineralized ECM region. Based on our analyses using reference spectra 
obtained from type I collagen (Fig. S2a) and synthetic collagen Gly-Pro-Hyp tripeptide (Fig. 
S2b), spectra obtained between days 1-4 were dominated by cell-specific tryptophan, nucleic 
acid, and tyrosine bands at 757, 782, and 827 cm-1, respectively.[32, 34] No clear collagen-specific 
bands were found, at least not until significant mineral deposition had occurred. For this reason, 
the band at ~854 cm-1 was assigned to the collagen proline ν(C-C) vibration between days 8-28, 
but at earlier time intervals this band would contain greater contributions from cell tyrosine δ(C-
C-H), valine ν(C-C), and/or polysaccharide γ(C-O-C) vibrations.[31, 32] The extent of spectral 
mixing between cell and collagen would also depend on the height of the bone nodule from the 
ECM layer, including the number of cells present at the surfaces or embedded inside the bone 
nodules.[39-41] Spectral mixing effects may also apply to the amide III, CH2-wag, and amide I 
regions between 1200-1320, 1420-1500, and 1630-1700 cm-1, respectively.[31] 
     A major lipid cell culture component was also identified. As shown in Fig. S3a-b, a spectrum 
taken from the poorly mineralized region at day-17 contained bands at 890, 920, 1061, 1128, 
1177, 1295, 1441, 1727, and 1741 cm-1. These bands were characteristic of triglycerides and 
their band positions coincided with those shown in the reference spectrum of the triglyceride 
mixture in Fig. S2c and those reported in the literature.[42] Although, bone triglycerides have 
been detected by chromatography [43] and NMR spectroscopy,[44] this is the first study in which 
they have been detected under osteogenic differentiation conditions by Raman microscopy. 
Previous studies have shown that primary osteogenic Sca-1- cells have some limited capacity to 
form lipid vacuoles after 21-days under adiopogenic differentiation conditions.[17] These findings 
support other studies, which have proposed that osteogenic cell lineages can also produce 
lipids.[45, 46]  
     Spectra acquired from the more granular region at day-14 (Fig. S3c-d) also gave rise to 
additional set of bands that were distinct from cell proteins, bone mineral, and triglycerides. The 
bands at 854, 939, 1045, 1081, 1125, 1339, and 1419 cm-1 resembled type I collagen, but were 
more pronounced, whereas the CH2-wag band between 1452-1458 cm-1 was broader and more 
symmetrical when compared to that typically encountered for type I collagen (Fig. S2a). The 
band at ~1377 cm-1 in Fig. S3e was also not typical of type I collagen. As shown in Fig. S3d, the 
von Kossa image acquired from the granular region was not stained for inorganic phosphate and 
thus indicated the presence of a soluble ECM component. We propose that some of these 
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additional bands, especially the band at 1377 cm-1 originated from the δ(CH3) bending mode of 
proteoglycans and/or glycosaminoglycans (GAGs), which have been reported to occur at ~1375 
cm-1 in subchondral bone.[33] The presence of proteoglycans and/or GAGs in our osteogenic 
cultures was also supported by the reference spectrum obtained from proteoglycan (Fig. S3d), 
which also contained the δ(CH3) band at ~1374 cm-1. More importantly, proteoglycans and 
GAGs are known to be expressed by calvarial tissues and pre-osteoblast cells, owing to their 
importance in mediating cell proliferation and differentiation activities, as well as mineralization 
in an inhibitory and/or stimulatory manner.[47-50]  
     After key cell culture components had been characterized, curve-fit analyses were performed 
to extract information on cell activity and mineralization. The phase of the mineral formed in 
culture was also examined using the mineral crystallinity parameter and the mineral v1(PO43-) 
band position, whereas collagen crosslinks and disorder/order ratios were used to evaluate the 
quality of the matrix. These spectroscopic parameters will be discussed in turn, including how 
bone formed at day-28 compared to that of calvarial tissues obtained from postnatal mice at day-
1 (PN1) and day-56 (PN56). 
 
Nucleic acid/protein ratios 
 
Cell activities were evaluated using nucleic acid/protein ratios, which had previously been used 
to determine the differentiation and/or proliferation status of embryonic stem cells and primary 
mouse osteoblast cells.[27, 51] Nucleic acid/protein ratios can be obtained from the ratio of the cell 
nucleic acid v(O-P-O) band at ~782 cm-1 to one of the cell protein tryptophan (Typ), proline 
(Pro) or general matrix CH2-wag bands at 757, 853, or 1450 cm-1, respectively.[27, 34, 51] Given 
that Sca-1- cell cultures would eventually produce collagen and triglyceride components, nucleic 
acid/Typ ratio was considered as the most representative measure of early cell activity. As shown 
in Fig. 2a, nucleic acid/Typ ratios declined dramatically after day-1 because of the increased 
differentiation of Sca-1- osteoprogenitor/stem cells into the more mature osteoblast cell 
phenotype. The decline in nucleic acid/Typ ratios is most likely explained by increased matrix 
synthesis with differentiation, with DNA levels remaining constant as cell proliferation is down-
regulated.[52] Given that mineral deposition was first detected at day-8, the down-regulation in 
cell proliferation would have occurred prior to this time point. Although, nucleic acid/Typ ratios 
appeared to decline consistently throughout the 28-day culture period, we advise against using 
this parameter once significant mineralization has occurred because: (1) the down-regulation in 
cell proliferation is linked to increased matrix synthesis[52] and that (2) with increased incubation 
time, the cell-specific Typ protein band at 757 cm-1 would gain greater spectral contributions 
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The mineralization of osteogenic cultures was evaluated using mineral/matrix ratios derived 
from the mineral v1(PO43-) band between 955-960 cm-1 and the matrix proline band at 853 cm-1. 
As shown in Fig. 2b, mineral was not detected spectroscopically until day-8, which was later 
confirmed by von Kossa staining (Fig. 1e-f). However, mineralization decreased on day-14, but 
then increased again between days 17-28. This bimodal mineralization behavior contrasts with 
the linear mineralization trends reported throughout the 28-day culture period for human primary 
osteoblast (HOb) and osteoblast-like U20S cells.[53] The bimodal mineralization trend found in 
this study could in part be attributed to the limited number of Raman spectroscopic 
measurements that can be obtained from suspected mineralizing sites for a given slide when 
compared to mineral staining techniques. Although, the amount of mineral formed at day-14 (Fig 
2b) was considered low compared to mineral formed at other time intervals (Fig. 2b), it still 
coincided with the time point in which osteogenic Sca-1- cell cultures had previously been shown 
to express the osteogenic markers, alkaline phosphatase (ALP) and Runt-related transcription 
factor 2 (Runx2).[16]  
   The amount of mineral formed in vitro at day-28 was comparable to that found in native 
calvarial tissue from PN1 mice (Fig. 2b). The latter result was supported by a previous X-ray and 
FTIR spectroscopic study, whereby the extent of calcification formed in a 30-day old osteoblast 
cell culture model, derived from embryonic chick calvaria, was similar to that found in late chick 
embryonic tissue and early chick postnatal tibiae.[54] In another X-ray and FTIR spectroscopic 
study, the mineral phase between 12-day old MC3T3-E1 osteoblast cell cultures and 30-day old 
mouse calvarial tissues were also reported to be similar.[19]  
   In contrast, the reason into why the mineral/matrix ratio of PN56 mice trended lower compared 
to PN1 mice and mineral formed in vitro at day-28 was not initially apparent (Fig. 2b). In a 
previous Raman spectroscopic study, calvarial tissues from PN1, PN3, PN7, and PN14 mice 
exhibited similar mineral/matrix ratios (ca. 960/1665 cm-1 ratios), but the ratios were still 
significantly lower when compared to 6-month old calvarial tissue.[55] Interestingly, another 
study reported that trypsinized collagen extracts from 6-month old mouse calvarial tissue were 
not completely mineralized, indicating that non-mineralized areas co-existed next to mineralized 
collagen.[56] We conjecture that the low mineral/matrix ratio exhibited by PN56 mice was the 
result of incomplete mineralization of parietal bone. More specifically, the cranial vault of PN56 
mice may have still been expanding to accommodate the growing brain,[57] and therefore new 
parietal bone formed outwards from the sagittal suture region may not have been completely 
mineralized, leading to lower mineral/matrix ratios. 
   Although the current study and prior work have primarily focused on evaluating the 
mineralization capacity specific to Sca-1- cells under osteogenic differentiation conditions,[16, 17]  
studies into how this in vitro osteogenic model compares with other established osteoblast cell 
lines or primary cell cultures have yet to be performed.[58, 59] Notwithstanding, the immortalized 
pre-osteoblast MC3T3-E1 cell line has also been shown to express the stem cell marker, Sca-1, 
which is not unexpected given that this cell line is also derived from newborn mouse calvaria.[18] 
Given that both Sca-1- and MC3T3-E1 cells also express the early osteogenic differentiation 
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markers, Runx2 and ALP, [16, 17, 60] suggest that these cell phenotypes would share similar 
mineralization outcomes in vitro. While MC3T3-E1 cell cultures exhibit cell proliferation rates 
and mineralization outcomes that were comparable to those reported for primary HOb cells, ALP 
activity and Runx2 gene expression were, however, significantly different because of species-
specific differences.[60] On the other hand, continuous cell passaging studies have shown that 
MC3T3-E1 cells can retain their osteogenic capacity up to 30-passages,[61] while Sca-1- cells lose 
their ability to differentiate into bone at 6-passages.[16] Further comparative studies would still be 
needed to ascertain whether the limited self-renewal capacity exhibited by the Sca-1- in vitro 
osteogenic model would better reflect the inherent heterogeneity exhibited by bone formed in 
vitro by primary HOb cells.[59] 
 
Mineral crystallinity and mineral phase 
 
In bone Raman spectroscopy, bandwidths of the mineral v1(PO43-) peaks can convey information 
on mineral crystallinity, with narrower bandwidths reflecting more ordered mineral crystallites. 
[62] Moreover, Raman measure of mineral crystallinity has been shown to be linearly correlated 
with: (1) mineral crystal size measurements obtained by X-ray diffraction,[63, 64] and (2) percent 
of B-type carbonate (CO3) content of synthetic carbonated hydroxyapatites (0.3-8 % CO3).[65, 66] 
As discussed previously, bone mineral was not detected until day-8 and therefore the bandwidth 
measurements shown at day-1 and day-4 in Fig. 2c (13.9 ± 3.3 and 13.8 ± 0.5 cm-1, respectively) 
reflect those of the faint ECM matrix band and not of actual bone mineral. As shown in Fig. 2c, 
mineral formed at day-8 was found to be crystalline (17.8 ± 1.2 cm-1), but still within the ranges 
found for native calvarial bone from PN1 and P56 mice (15.4 ± 0.4 and 18.6 ± 0.2 cm-1, 
respectively), At days-14, -17, and -25, bone mineral became less crystalline (24.0 ± 0.5, 23.7 ± 
0.5, and 22.5 ± 4.0 cm-1, respectively). At day-28, bone mineral crystallinity (17.8 ± 0.5 cm-1) 
was comparable to PN1 and PN56 mice. Narrower ranges in mineral crystallinity values reported 
for certain osteoblast-like cell lines have, in part, been associated with dystrophic mineral 
precipitations.[53] However, cell culture and postnatal mineral crystallinity measurements found 
in this study were considerably broader when compared to synthetic hydroxyapatite standard 
(HA, 10.1 ± 0.01 cm-1).          
   With temporal variations in bone mineral crystallinity shown in Fig. 2c, one would also expect 
to find variations in the corresponding mineral v1(PO43-) band positions. In our previous study 
involving the in vitro intramembranous mineralization of calvarial tissues from fetal-day 18.5-
old mice, we found that band positions at ~955 cm-1 was indicative of octacalcium phosphate 
(OCP)-like mineral phases, whereas band positions between 957-962 cm-1 reflected more 
mature, carbonated-apatitic mineral phases.[25] The temporal maturation of precursor mineral 
phases has been reported in other osteogenic models.[27, 67] By regressing the mineral crystallinity 
parameter against band positions gave rise to a significant and positive linear correlation (R2 = 
0.87, p < 0.001) (Fig. 2d). The plot shows that mineral phases formed in culture at days 8 and 28 
and in calvarial tissue from PN1 and PN56 mice were mature. In contrast, mineral phases formed 
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in culture at days 14, 17, and 25 were less mature and more OCP-like. The regression plot also 
included the hydroxyapatite standard, which was found to be highly crystalline. However, as 
shown in Fig. S2e, the hydroxyapatite standard was deficient in B-type carbonate substitution 
unlike bone mineral formed at day-28 (Fig. 1n) and calvarial tissue from PN1 and PN56 mice 
(Fig. S2f-g), which contained the v1(CO32-) band at ~1070 cm-1. Taken together, we show that 
mineral crystallinity is strongly related with the phase of the mineral formed in culture.  
 
Collagen crosslinks ratio 
 
The quality of bone matrix and the degree of mineral formed in vivo are linked to the relative 
divalent to trivalent collagen crosslinks content.[68] Divalent collagen crosslinks are reducible 
intermediates, which include dehydro-dihydroxylysinonorleucine (deH-DHLNL) and dehydro-
hydroxylysinonorleucine (deH-HLNL).[69] With time, these divalent collagen crosslinks mature 
into the more stable trivalent collagen crosslinks, which include pyridinoline (PYD) and 
deoxypyridinoline (DPD), amongst others.[70] The relative amounts of trivalent (PYD) to divalent 
(deH-DHLNL) collagen crosslinks can be estimated spectroscopically from the ratio of the 
deconvolved amide I bands at ~1667 cm-1 and ~1693 cm-1, respectively.[71] At present, 
spectroscopic measures of collagen crosslinks ratios have predominantly been obtained from 
mineralizing and non-mineralizing MC3T3-E1 osteoblastic cell line.[72-74] As shown in Fig. 2e, 
collagen crosslinks ratios were unremarkably consistent throughout the 28-day culture period, 
with the exception of the large variation observed at day-4. In general, collagen crosslinks ratio 
found at day-28 was comparable to that found in calvarial tissue from PN1 mice, but was non-
significantly lower when compared to PN56 mice. Although, age-related changes in collagen 
crosslink content in calvarial tissues from postnatal mice have yet to be examined, recent 
chromatographic analyses have shown that calvarial tissues obtained from adult mice contained 
higher amounts of immature collagen crosslinks compared to long bones.[75, 76] In addition, older 
calvarial tissues have been reported to exhibit higher osteoclastic activity compared to long 
bones, which could in part explain why collagen crosslinks ratios found in PN56 mice were 
considerably lower when compared to PN1 mice.  
 
Collagen disorder/order ratio 
 
The spectral region between 1200 and 1300 cm-1 was also found to contain information on the 
conformation of proteins expressed by Sca-1- cells, either internally or externally. As shown in 
Fig. 2f the ratio between the amide III sub-bands at ~1246 cm-1 (β-sheet, disordered structure) 
and ~1264 cm-1 (α-helix, ordered structure) [32, 34] were used to evaluate: (1) the relative amounts 
of disordered to ordered proteins expressed by Sca-1- cells between days 1-4, and (2) the 
structural organization of the collagenous matrix during the mineralization phase through days 8-
28. Firstly, the high initial disorder/order ratio displayed at day-1 was attributed to the high 
initial expression of disordered proteins by Sca-1- cells. This was not entirely unexpected given 
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that osteogenic cultures were known to be more active during the early cell proliferation 
phase.[52] While changes in cell protein conformations are essential for the normal functioning of 
cell processes,[77, 78] we speculate that the reduced disorder/order ratio found at day-4 was 
attributed to the increased expression of more ordered proteins by Sca-1- cells. More ordered 
proteins would also include α-helical collagen, which is known to be formed within days of 
osteogenic induction in culture.[52, 79, 80] The disorder/order ratios continued to decline steadily 
through days 8-28, which was facilitated by the progressive stabilization and co-alignment of the 
collagen fibrils with the apatitic mineral crystallites. Interestingly, the disorder/order ratio found 
in culture at day-28 was significantly higher than those of calvarial tissue from PN1 and PN56 
mice. These differences could in part be explained by the fact that bone mineral formed in 2-
dimensional osteogenic cell cultures do not fully capture the hierarchical or anisotropic collagen 
organization found in native bone.[81-83] A recent in situ second-harmonic-generation (SHG) 
study has also shown that collagen fibers produced by pre-osteoblast MC3T3-E1 cell cultures are 
in general less structured and nonspecifically orientated due to immature structure.[84] In 
addition, the collagen amide III band at ~1270 cm-1 is known to be strongly polarization 
dependent compared to the ~1240 cm-1 band,[36, 37] and therefore would be more sensitive to the 
orientation of collagen fibrils, especially in native bone. It has recently been shown that the 
orientation and alignment of cells in osteogenic culture can be increased by using artificially-
orientated collagen scaffolds[85] or by mechanical stimulation.[86] These tissue-engineering 
approaches could be employed to provide tissues with the higher degree of anisotropic collagen 
found in native bone.  
 
Limitation of the current study   
 
While mineral crystallinity of bone formed by Sca-1- cell cultures and postnatal bone were found 
to be linearly correlated with mineral band position (Fig. 2d), the high initial mineral/matrix 
ratios observed at day-8 (Fig. 2b) still requires further investigation. More specifically, the 
current study would have benefited from additional replicate experiments to determine whether 
the high initial mineral/matrix ratios observed at day-8 was an outlier or related to the normal 
biological variation inherent to Sca-1- stem/progenitor cells isolated fetal mouse calvarial tissues. 
Previous in vivo organ culture spectroscopic studies have also shown that the mineralization and 
mineral crystallinity kinetics of neonatal mouse calvarias are different. In the latter study, 
mineral/matrix ratios was found to increase in aperiodic step-like increments over a 6-day period, 




The current work shows that osteogenic cell cultures, enriched by calvarial-derived Sca-1- 
stem/progenitor cells, can produce bone that is comparable to 1-day old postnatal bone in terms 
of mineralization, mineral crystallinity, and collagen crosslink ratios. Additional new insights 
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into the mineral phase of the cell cultures could be obtained by regressing the mineral 
crystallinity parameter against the mineral band position. Raman spectra of osteogenic cell 
cultures were found to be considerably more complex with the detection of additional 
triglyceride and glycosaminoglycan-like components. Through the characterization of cell- and 
collagen-specific vibrational modes, we show that the down-regulation of cell activity preceded 
mineralization. However, osteogenic cell cultures could not fully replicate the high degree of 
collagen fibril order found in native bone. Further investigation into using orientated collagen 
scaffolds or mechanical stimulation maybe required to produce bone with increased collagen 
fibril order that is inherent to native bone. In conclusion, our data provides new insights into the 
composition of osteogenic cell cultures and the quality of mineral and matrix formed by Sca-1- 
stem/progenitor cells. Raman spectroscopic measures of bone quality used in this study could 
equally be used to evaluate ex vivo specimens obtained from preclinical models that are used in 
tissue engineering research. 
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In this Raman spectroscopic study, we examined the quality of bone formed in vitro by fetal 
mouse calvarial stem/progenitor cells under osteogenic differentiation conditions. We 
characterized bone mineral and matrix cell culture components and detected the presence of lipid 
and glycosaminoglycan-like components. Bone formed in vitro at day-28 was similar to 1-day 
old postnatal mouse calvarial bone in terms of mineralization, mineral crystallinity, and collagen 
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